$2.26 Billion is the total value of Nantahala Capital Management's 122 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 33.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $554,229,000 | +15.9% | 2,700,000 | +25.6% | 24.52% | +45.7% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $144,835,000 | +0.9% | 2,149,201 | +1.2% | 6.41% | +26.9% |
| IWM | Buy | ISHARES TRrussell 2000 etf | $75,545,000 | +696.6% | 368,029 | +763.3% | 3.34% | +900.6% |
| CDXS | Buy | CODEXIS INC | $69,758,000 | -30.6% | 3,383,049 | +5.3% | 3.09% | -12.7% |
| SGMS | Buy | SCIENTIFIC GAMES CORP | $67,246,000 | +975.8% | 1,144,613 | +1123.8% | 2.98% | +1252.3% |
| MLHR | Buy | MILLERKNOLL INC | $56,096,000 | -2.3% | 1,623,135 | +10.8% | 2.48% | +22.9% |
| TA | TRAVELCENTERS OF AMERICA INC | $54,670,000 | -16.8% | 1,272,570 | 0.0% | 2.42% | +4.7% | |
| TNL | Sell | TRAVEL PLUS LEISURE COcall | $53,253,000 | -3.6% | 919,100 | -8.1% | 2.36% | +21.1% |
| QURE | Buy | UNIQURE NV | $50,803,000 | +3.6% | 2,811,459 | +19.0% | 2.25% | +30.4% |
| IMAX | Sell | IMAX CORP | $50,513,000 | +1.2% | 2,668,431 | -4.6% | 2.24% | +27.3% |
| TNL | Sell | TRAVEL PLUS LEISURE CO | $50,261,000 | -3.4% | 867,464 | -7.8% | 2.22% | +21.5% |
| CASH | Sell | META FINL GROUP INC | $47,780,000 | -10.6% | 869,993 | -2.9% | 2.11% | +12.4% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $46,792,000 | -25.0% | 2,692,303 | -5.6% | 2.07% | -5.7% |
| KROS | Buy | KEROS THERAPEUTICS INC | $44,419,000 | -4.7% | 816,830 | +2.5% | 1.96% | +19.8% |
| IMAX | Sell | IMAX CORPcall | $41,481,000 | -3.1% | 2,191,300 | -8.7% | 1.84% | +21.8% |
| GDEN | Sell | GOLDEN ENTMT INC | $40,103,000 | -25.9% | 690,606 | -35.5% | 1.77% | -6.9% |
| LXFR | Buy | LUXFER HOLDINGS PLC | $37,504,000 | -8.3% | 2,232,389 | +5.4% | 1.66% | +15.3% |
| RDVT | Buy | RED VIOLET INC | $35,946,000 | -11.5% | 1,261,251 | +23.2% | 1.59% | +11.3% |
| AMPH | New | AMPHASTAR PHARMACEUTICALS INput | $35,900,000 | – | 1,000,000 | +100.0% | 1.59% | – |
| DXPE | Sell | DXP ENTERPRISES INC | $32,215,000 | +2.6% | 1,189,179 | -2.8% | 1.42% | +29.0% |
| RMR | Sell | RMR GROUP INCcl a | $29,914,000 | -10.5% | 961,851 | -0.2% | 1.32% | +12.5% |
| IMXI | Sell | INTERNATIONAL MNY EXPRESS IN | $29,390,000 | +14.3% | 1,425,985 | -11.5% | 1.30% | +43.6% |
| PAYA | Buy | PAYA HOLDINGS INC | $24,085,000 | -0.0% | 4,110,073 | +8.2% | 1.07% | +25.7% |
| IMTX | Buy | IMMATICS N.V | $23,528,000 | -40.0% | 2,944,659 | +0.9% | 1.04% | -24.6% |
| PTON | Sell | PELOTON INTERACTIVE INCcall | $23,477,000 | -27.1% | 888,600 | -1.3% | 1.04% | -8.2% |
| DHX | Buy | DHI GROUP INC | $22,894,000 | -1.5% | 3,847,769 | +3.3% | 1.01% | +23.8% |
| APEN | Sell | APOLLO ENDOSURGERY INC | $22,536,000 | -28.9% | 3,724,899 | -1.0% | 1.00% | -10.7% |
| XBI | Sell | SPDR SER TRput | $22,470,000 | -69.1% | 250,000 | -61.5% | 0.99% | -61.2% |
| ALTG | Sell | ALTA EQUIPMENT GROUP INC | $22,330,000 | -21.6% | 1,806,607 | -7.2% | 0.99% | -1.5% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $18,124,000 | -14.4% | 4,346,327 | +6.6% | 0.80% | +7.7% |
| SYK | New | STRYKER CORPORATIONput | $18,100,000 | – | 67,700 | +100.0% | 0.80% | – |
| SMLR | Buy | SEMLER SCIENTIFIC INC | $17,687,000 | -30.9% | 356,875 | +27.9% | 0.78% | -13.0% |
| QURE | Sell | UNIQURE NVcall | $16,082,000 | -63.2% | 890,000 | -57.7% | 0.71% | -53.7% |
| PTON | Buy | PELOTON INTERACTIVE INC | $15,597,000 | +326.1% | 590,330 | +476.8% | 0.69% | +434.9% |
| ATGE | New | ADTALEM GLOBAL ED INCput | $14,855,000 | – | 500,000 | +100.0% | 0.66% | – |
| BBQ | Sell | BBQ HLDGS INC | $14,407,000 | -9.0% | 951,559 | -4.8% | 0.64% | +14.4% |
| RDI | Sell | READING INTL INCcl a | $13,810,000 | -1.7% | 3,226,656 | -7.2% | 0.61% | +23.7% |
| DRI | New | DARDEN RESTAURANTS INCput | $13,295,000 | – | 100,000 | +100.0% | 0.59% | – |
| FBIO | Sell | FORTRESS BIOTECH INC | $12,026,000 | -47.1% | 8,842,525 | -2.7% | 0.53% | -33.4% |
| CUE | Sell | CUE BIOPHARMA INC | $10,952,000 | -61.9% | 2,244,359 | -11.6% | 0.48% | -52.0% |
| Buy | DARIOHEALTH CORP | $10,021,000 | -45.3% | 1,716,007 | +21.6% | 0.44% | -31.2% | |
| Sell | APTOSE BIOSCIENCES INC | $9,958,000 | -3.0% | 7,322,189 | -3.7% | 0.44% | +22.2% | |
| New | FINTECH ACQUISITION CORP VI | $9,820,000 | – | 999,992 | +100.0% | 0.43% | – | |
| IIII | Sell | INSU ACQUISITION CORP III | $9,773,000 | -0.3% | 995,173 | -0.5% | 0.43% | +25.2% |
| FTCV | Sell | FINTECH ACQUISITION CORP V | $9,457,000 | -3.8% | 958,137 | -3.4% | 0.42% | +20.8% |
| HCA | HCA HEALTHCARE INC | $8,922,000 | -2.4% | 35,600 | 0.0% | 0.40% | +22.7% | |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $8,862,000 | – | 1,071,536 | +100.0% | 0.39% | – |
| TSHA | Sell | TAYSHA GENE THERAPIES INC | $8,697,000 | -48.7% | 1,333,947 | -8.4% | 0.38% | -35.5% |
| Sell | ARYA SCIENCES ACQUISITN CORP | $8,423,000 | -13.1% | 865,633 | -13.4% | 0.37% | +9.4% | |
| SFT | Sell | SHIFT TECHNOLOGIES INCcl a | $8,208,000 | -41.5% | 3,730,912 | -9.4% | 0.36% | -26.5% |
| HLF | Sell | HERBALIFE NUTRITION LTDcall | $8,127,000 | -28.6% | 267,700 | -3.7% | 0.36% | -10.0% |
| HERA | Sell | FTAC HERA ACQUISITION CORP | $7,832,000 | -13.9% | 800,001 | -14.1% | 0.35% | +8.4% |
| SRL | Sell | SCULLY ROYALTY LTD | $7,585,000 | +6.1% | 772,437 | -4.3% | 0.34% | +33.3% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $7,361,000 | -44.9% | 3,200,593 | +13.8% | 0.33% | -30.6% |
| MAX | Buy | MEDIAALPHA INCcl a | $7,241,000 | +26.6% | 437,494 | +18.1% | 0.32% | +59.2% |
| Sell | PAR TECHNOLOGY CORPnote 2.875% 4/1 | $6,953,000 | -21.2% | 5,785,000 | -3.6% | 0.31% | -0.6% | |
| SSKN | STRATA SKIN SCIENCES INC | $6,726,000 | +0.3% | 4,575,812 | 0.0% | 0.30% | +26.3% | |
| Buy | AURA BIOSCIENCES INC | $6,644,000 | +294.8% | 301,990 | +204.6% | 0.29% | +398.3% | |
| VMD | Sell | VIEMED HEALTHCARE INC | $6,443,000 | -13.3% | 1,293,812 | -9.1% | 0.28% | +9.2% |
| Sell | AKUMIN INC | $6,193,000 | -44.0% | 5,578,992 | -11.7% | 0.27% | -29.6% | |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $5,890,000 | -12.9% | 1,893,997 | -5.3% | 0.26% | +9.7% |
| CRIS | Buy | CURIS INC | $5,898,000 | -48.2% | 2,478,265 | +3.6% | 0.26% | -34.9% |
| RILY | Sell | B. RILEY FINANCIAL INC | $5,492,000 | -33.8% | 78,508 | -15.9% | 0.24% | -16.8% |
| ONTF | New | ON24 INC | $5,051,000 | – | 384,088 | +100.0% | 0.22% | – |
| Sell | AVALO THERAPEUTICS INC | $4,804,000 | -60.5% | 6,849,547 | -4.1% | 0.21% | -50.1% | |
| PWP | Buy | PERELLA WEINBERG PARTNERS | $4,750,000 | +32.8% | 502,676 | +80.7% | 0.21% | +66.7% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $4,126,000 | -38.4% | 4,954,882 | -6.0% | 0.18% | -22.1% |
| VRM | VROOM INCcall | $3,990,000 | -75.3% | 1,500,000 | 0.0% | 0.18% | -68.9% | |
| NPCE | Buy | NEUROPACE INC | $3,984,000 | +29.2% | 485,303 | +58.6% | 0.18% | +61.5% |
| NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $3,878,000 | -27.3% | 893,561 | -13.2% | 0.17% | -8.5% |
| KURA | Sell | KURA ONCOLOGY INCcall | $3,874,000 | +10.7% | 240,900 | -3.6% | 0.17% | +39.0% |
| W | New | WAYFAIR INCcl a | $3,843,000 | – | 34,688 | +100.0% | 0.17% | – |
| Sell | HELIOGEN INC | $3,385,000 | -71.8% | 643,599 | -17.0% | 0.15% | -64.5% | |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $3,269,000 | +46.7% | 516,817 | -9.3% | 0.14% | +85.9% |
| ARYD | Sell | ARYA SCIENCES ACQU CORP IVcl a | $3,193,000 | -19.3% | 325,848 | -18.4% | 0.14% | +1.4% |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $3,152,000 | -53.0% | 913,597 | -9.2% | 0.14% | -41.1% |
| BRPM | Sell | B RILEY PRINCIPAL 150 MERGER | $2,994,000 | -15.4% | 301,786 | -13.7% | 0.13% | +6.5% |
| STIM | New | NEURONETICS INC | $2,667,000 | – | 880,155 | +100.0% | 0.12% | – |
| IMV | Sell | IMV INC | $2,632,000 | +5.0% | 1,866,491 | -9.2% | 0.12% | +31.8% |
| ANGN | Sell | ANGION BIOMEDICA CORP | $2,487,000 | -32.3% | 1,173,162 | -7.4% | 0.11% | -14.7% |
| IMAC | Sell | IMAC HLDGS INC | $2,308,000 | -15.4% | 2,241,113 | -6.3% | 0.10% | +6.2% |
| KROS | Buy | KEROS THERAPEUTICS INCcall | $2,279,000 | -1.9% | 41,900 | +5.5% | 0.10% | +23.2% |
| ACER | Sell | ACER THERAPEUTICS INC | $2,256,000 | +9.8% | 777,820 | -13.7% | 0.10% | +38.9% |
| ZVO | Sell | ZOVIO INC | $2,144,000 | -43.4% | 2,613,763 | -12.3% | 0.10% | -28.6% |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $2,104,000 | -47.5% | 9,436,512 | -3.4% | 0.09% | -34.0% |
| Sell | HYPERFINE INC | $2,112,000 | -59.5% | 596,480 | -17.0% | 0.09% | -49.2% | |
| IDWM | Sell | IDW MEDIA HLDGS INCcl b | $2,047,000 | -16.7% | 1,118,406 | -9.0% | 0.09% | +5.8% |
| PAYA | New | PAYA HOLDINGS INCcall | $1,758,000 | – | 300,000 | +100.0% | 0.08% | – |
| IMTXW | Sell | IMMATICS N.V*w exp 07/01/202 | $1,740,000 | -63.0% | 1,035,613 | -3.3% | 0.08% | -53.3% |
| FARADAY FUTRE INTLGT ELCTR I | $1,746,000 | -6.2% | 350,000 | 0.0% | 0.08% | +16.7% | ||
| PAYO | Sell | PAYONEER GLOBAL INC | $1,719,000 | -41.3% | 385,366 | -3.3% | 0.08% | -26.2% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,638,000 | -42.5% | 819,101 | -9.7% | 0.07% | -28.0% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $1,598,000 | -36.7% | 2,420,789 | -12.3% | 0.07% | -20.2% |
| FVAM | Sell | 5 01 ACQUISITION CORP | $1,600,000 | -10.7% | 162,430 | -10.7% | 0.07% | +12.7% |
| LVTX | Sell | LAVA THERAPEUTICS NV | $1,470,000 | -25.9% | 334,164 | -7.4% | 0.06% | -7.1% |
| MILE | Sell | METROMILE INC | $1,377,000 | -43.8% | 1,043,514 | -6.8% | 0.06% | -29.1% |
| ALEC | New | ALECTOR INC | $1,351,000 | – | 94,779 | +100.0% | 0.06% | – |
| XGN | Sell | EXAGEN INC | $1,279,000 | -41.2% | 159,253 | -14.8% | 0.06% | -25.0% |
| Sell | IN8BIO INC | $1,226,000 | -25.2% | 352,753 | -5.5% | 0.05% | -6.9% | |
| Sell | LUCID DIAGNOSTICS INC | $1,060,000 | -54.6% | 315,414 | -27.5% | 0.05% | -42.7% | |
| New | WEJO GROUP LIMITED | $857,000 | – | 214,966 | +100.0% | 0.04% | – | |
| Sell | UNICYCIVE THERAPEUTICS INC | $826,000 | -41.6% | 640,633 | -6.7% | 0.04% | -26.0% | |
| PWPPW | Buy | PERELLA WEINBERG PARTNERS*w exp 12/31/202 | $822,000 | -41.8% | 409,128 | +2.3% | 0.04% | -28.0% |
| Sell | TANGO THERAPEUTICS INC | $749,000 | -31.5% | 98,794 | -1.2% | 0.03% | -13.2% | |
| AKBA | Sell | AKEBIA THERAPEUTICS INCcall | $693,000 | -69.3% | 965,800 | -3.4% | 0.03% | -61.2% |
| Sell | COGNITION THERAPEUTICS INC | $540,000 | -59.2% | 196,402 | -6.3% | 0.02% | -48.9% | |
| TACT | Sell | TRANSACT TECHNOLOGIES INC | $504,000 | -39.6% | 71,335 | -6.9% | 0.02% | -24.1% |
| ELOX | Sell | ELOXX PHARMACEUTICALS INC | $434,000 | -31.3% | 774,767 | -13.4% | 0.02% | -13.6% |
| HTGM | Sell | HTG MOLECULAR DIAGNOSTICS IN | $397,000 | -78.1% | 285,963 | -14.6% | 0.02% | -71.9% |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $412,000 | -24.0% | 258,957 | -13.1% | 0.02% | -5.3% |
| FTCVW | FINTECH ACQUISITION CORP V*w exp 12/31/202 | $317,000 | -35.3% | 333,331 | 0.0% | 0.01% | -17.6% | |
| KTRA | KINTARA THERAPEUTICS INC | $264,000 | -21.9% | 663,279 | 0.0% | 0.01% | 0.0% | |
| Sell | FALCON MINERALS CORP*w exp 07/21/202 | $256,000 | +109.8% | 674,561 | -23.2% | 0.01% | +175.0% | |
| Sell | GUARDFORCE AI CO LTD*w exp 10/01/202 | $142,000 | -57.4% | 374,205 | -37.6% | 0.01% | -50.0% | |
| New | FINTECH ACQUISITION CORP VI*w exp 03/31/202 | $143,000 | – | 249,998 | +100.0% | 0.01% | – | |
| BRPMW | Sell | B RILEY PRINCIPAL 150 MERGER*w exp 03/01/202 | $109,000 | -39.8% | 120,686 | -3.4% | 0.01% | -16.7% |
| New | TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $117,000 | – | 235,294 | +100.0% | 0.01% | – | |
| HERAW | Sell | FTAC HERA ACQUISITION CORP*w exp 02/28/202 | $97,000 | -59.1% | 222,949 | -10.8% | 0.00% | -50.0% |
| IIIIW | INSU ACQUISITION CORP III*w exp 12/31/202 | $67,000 | -63.8% | 333,332 | 0.0% | 0.00% | -57.1% | |
| MILEW | Sell | METROMILE INC*w exp 02/09/202 | $66,000 | -15.4% | 507,460 | -9.1% | 0.00% | 0.0% |
| OCGN | Sell | OCUGEN INC | $55,000 | -81.0% | 16,571 | -73.9% | 0.00% | -80.0% |
| New | QUALTEK SERVICES INC*w exp 02/14/202 | $56,000 | – | 96,244 | +100.0% | 0.00% | – | |
| BRPMU | Exit | B RILEY PRINCIPAL 150 MERGERunit 99/99/9999 | $0 | – | -9 | -100.0% | 0.00% | – |
| HERAU | Exit | FTAC HERA ACQUISITION CORPunit 02/28/2026 | $0 | – | -9 | -100.0% | 0.00% | – |
| IIIIU | Exit | INSU ACQUISITION CORP IIIunit 12/31/2026 | $0 | – | -4 | -100.0% | 0.00% | – |
| ROCRW | Exit | ROTH CH ACQUISITION III CO*w exp 02/26/202 | $0 | – | -99,749 | -100.0% | -0.00% | – |
| Exit | BAKKT HOLDINGS INC | $0 | – | -52,499 | -100.0% | -0.02% | – | |
| HOOK | Exit | HOOKIPA PHARMA INC | $0 | – | -473,566 | -100.0% | -0.04% | – |
| ATXI | Exit | AVENUE THERAPEUTICS INC | $0 | – | -1,453,166 | -100.0% | -0.05% | – |
| CABA | Exit | CABALETTA BIO INC | $0 | – | -341,538 | -100.0% | -0.05% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -475,467 | -100.0% | -0.13% | – |
| BGFV | Exit | BIG 5 SPORTING GOODS CORPput | $0 | – | -200,000 | -100.0% | -0.13% | – |
| ZGNX | Exit | ZOGENIX INCcall | $0 | – | -236,400 | -100.0% | -0.14% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.15% | – |
| SPCE | Exit | VIRGIN GALACTIC HOLDINGS INCcall | $0 | – | -400,000 | -100.0% | -0.19% | – |
| PRTY | Exit | PARTY CITY HOLDCO INCcall | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -300,000 | -100.0% | -0.25% | – |
| LINC | Exit | LINCOLN EDL SVCS CORP | $0 | – | -1,003,024 | -100.0% | -0.26% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -481,782 | -100.0% | -0.28% | – |
| TDOC | Exit | TELADOC HEALTH INCput | $0 | – | -100,000 | -100.0% | -0.32% | – |
| FTVIU | Exit | FINTECH ACQUISITION CORP VIunit 06/24/2026 | $0 | – | -1,000,000 | -100.0% | -0.35% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -4,918,565 | -100.0% | -0.39% | – |
| Exit | FALCON MINERALS CORP | $0 | – | -2,374,707 | -100.0% | -0.41% | – | |
| Exit | ZOGENIX INCnote 2.750%10/0 | $0 | – | -14,000,000 | -100.0% | -0.49% | – | |
| SWAV | Exit | SHOCKWAVE MED INCput | $0 | – | -80,000 | -100.0% | -0.50% | – |
| SC | Exit | SANTANDER CONSUMER USA HLDGS | $0 | – | -395,176 | -100.0% | -0.58% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -400,000 | -100.0% | -1.58% | – |
| CVNA | Exit | CARVANA COcall | $0 | – | -203,700 | -100.0% | -1.66% | – |
| THC | Exit | TENET HEALTHCARE CORPcall | $0 | – | -875,900 | -100.0% | -2.52% | – |
| SGMS | Exit | SCIENTIFIC GAMES CORPcall | $0 | – | -1,559,300 | -100.0% | -3.67% | – |
| W | Exit | WAYFAIR INCcall | $0 | – | -807,700 | -100.0% | -5.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.